Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective.
about
Aflibercept: A Review of Its Use in the Management of Diabetic Eye Complications.Cost-Effectiveness of Ranibizumab Versus Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion: A UK Healthcare PerspectiveCost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema.Aflibercept in diabetic macular edema: evaluating efficacy as a primary and secondary therapeutic option.Diabetic macular edema, innovative technologies and economic impact: New opportunities for the Lombardy Region healthcare system?The Cost-Effectiveness of Ranibizumab Treat and Extend Regimen Versus Aflibercept in the UK.Ranibizumab: A Review of Its Use in the Treatment of Diabetic Retinopathy in Patients With Diabetic Macular Edema.
P2860
Q36013973-8A241177-073E-476B-92DF-23266E9C5C6CQ36526922-A2F79383-4B81-4A18-83CF-CDDC8196A020Q36796899-74B47128-9EC0-441B-A15F-2EB40D2B7912Q38937864-41E437CA-BDCA-44E2-B1F7-B813BDAB428BQ47250471-A65FDADA-151A-44C0-B3A4-937BAEC479C8Q51616989-0B12BD25-D49A-45A3-909D-2A4F64CE21CEQ55316713-F684DFCF-42FB-4EF0-990C-5C15D490DCE5
P2860
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@ast
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@en
type
label
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@ast
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@en
prefLabel
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@ast
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@en
P2093
P2860
P356
P1476
Cost-effectiveness of ranibizu ...... : a UK healthcare perspective.
@en
P2093
Jennifer Haig
Stephane A Régnier
Weiguang Xue
William Malcolm
P2860
P304
P356
10.2147/CEOR.S82556
P407
P577
2015-05-06T00:00:00Z